Access cutting-edge invasive aspergillosis treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Kansas City location
Access invasive aspergillosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related invasive aspergillosis treatment provided free
Check if you qualify for this invasive aspergillosis clinical trial in Kansas City, KS
No-Cost Study Care
Local to Kansas City
Convenient for KS residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).
Sponsor: F2G Biotech GmbH
Yes, this clinical trial (NCT05101187) has an active research site in Kansas City, KS that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for invasive aspergillosis treatment options in Kansas City, KS, this clinical trial (NCT05101187) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced invasive aspergillosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all invasive aspergillosis clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Kansas City — not just this study.
Browse Pulmonary Embolism Trials in Kansas City →